Evidence map›Paper›PMID 12499358›Full record

ArticleThe Journal of cell biology2002

The Cdc37 protein kinase-binding domain is sufficient for protein kinase activity and cell viability.

Paul Lee, Jie Rao, Albert Fliss, Emy Yang, Stephen Garrett, Avrom J Caplan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Conformational dynamics of the molecular chaperone Hsp90.Quarterly reviews of biophysics · 2011
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paul LeeDepartment of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jie Rao
Albert Fliss
Emy Yang
Stephen Garrett
Avrom J Caplan
Icahn School of Medicine at Mount Sinai · USRutgers, The State University of New Jersey · US

Funding

Interdisciplinary Program in Cell &Mol EndocrinologyT32DK007645 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DAVIES, TERRY FRANCIS · 1990 to 2009
$2.3M
ANDROGEN RECEPTOR DEGRADATIONR01DK060598 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CAPLAN, AVROM J. · 2002 to 2006
$1.4M
Sequence Specificity of a Metazoan Replication OriginF32GM066644 · NIGMS · BROWN UNIVERSITY · PI STREZOSKA, ZAKLINA · 2002 to 2002
$22k
NIDDK NIH HHS 5T32DK07645NIDDK NIH HHS DK60598NIDDK NIH HHS R01 DK060598NIDDK NIH HHS T32 DK007645NIGMS NIH HHS F32 GM066644NIGMS NIH HHS GM66644
6 · The paper itself

Abstract

Cdc37 is a molecular chaperone required for folding of protein kinases. It functions in association with Hsp90, although little is known of its mechanism of action or where it fits into a folding pathway involving other Hsp90 cochaperones. Using a genetic approach with Saccharomyces cerevisiae, we show that CDC37 overexpression suppressed a defect in v-Src folding in yeast deleted for STI1, which recruits Hsp90 to misfolded clients. Expression of CDC37 truncation mutants that were deleted for the Hsp90-binding site stabilized v-Src and led to some folding in both sti1Delta and hsc82Delta strains. The protein kinase-binding domain of Cdc37 was sufficient for yeast cell viability and permitted efficient signaling through the yeast MAP kinase-signaling pathway. We propose a model in which Cdc37 can function independently of Hsp90, although its ability to do so is restricted by its normally low expression levels. This may be a form of regulation by which cells restrict access to Cdc37 until it has passed through a triage involving other chaperones such as Hsp70 and Hsp90.

Indexed as

Drosophila ProteinsBinding SitesBlotting, WesternCell Cycle ProteinsGenetic Complementation TestGlutathione TransferaseHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsMAP Kinase Signaling SystemModels, BiologicalMolecular ChaperonesMutationOncogene Protein pp60(v-src)PlasmidsProtein BindingProtein FoldingCDC37 protein, S cerevisiaeCell Cycle ProteinsDrosophila ProteinsGlutathione TransferaseHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsMolecular ChaperonesOncogene Protein pp60(v-src)Protein-Tyrosine KinasesSaccharomyces cerevisiae Proteins

Identifiers

PMID12499358
PMCPMC2173992
OpenAlexW2105570564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.